Precision Medicine
Precision Medicine aims to target the right drug, to the right patient, at the right dose and the right time. Precision Medicine is a cutting-edge field of innovation that improves disease outcome by tailoring treatments to characteristics of patients.
Precision Medicine
|Experts
|Funding Opportunities
|Case Studies
|Events
|News
|Perspective
|Programmes
Precision Medicine improves the accuracy of diagnosis and prognosis, refines the selection of treatment, and increases therapeutic efficacy whilst decreasing the likelihood of side-effects. This approach triangulates between lots of data points: genes, proteins, other biomarkers, general health and phenotypic data, to place patients into stratified populations.
Precision medicine is an exciting and burgeoning area of health research that presents both economic and health benefits. The Health Team at Innovate UK Business Connect supports companies of various sizes, working across the sub-sectors of Precision Medicine. Precision Medicine is a particularly diverse and interdisciplinary area, and fruitful collaboration is crucial to innovation and enterprise. Innovate UK Business Connect is uniquely placed at the crossroads of multiple stakeholders in different sectors and facilitates key partnerships to advance this area of innovation forwards.
Related Opportunities
EUP OHAMR 2026 transnational call: New treatments to tackle Antimicrobial Resistance (AMR)
Opens: 18/11/2025 Closes: 02/02/2026
International call to explore new "Treatments and adherence to treatment protocols" to tackle AMR, total call budget of over 31 million Euro.
More Information
Innovate UK Growth Catalyst – Investor Partnerships Round 2
Opens: 10/12/2025 Closes: 03/02/2026
Grant funding for late-stage R&D projects of up to £2m in size, subject to aligned private investment through Innovate UK’s proven Investor Partnerships funding model.
More Information
Women in Innovation Awards 2025/26
Opens: 26/11/2025 Closes: 04/02/2026
Women founders or co-founders of UK registered SMEs can apply for a package of support that includes a grant of up to £75,000 and bespoke business support, to further their ambitious growth plans.
More Information
Global Health EDCTP3 Work Programme 2026
Opens: 19/01/2026 Closes: 04/03/2026
Global Health EDCTP3 2026 will fund up to €147m in research and innovation projects for sub-Saharan Africa, tackling tuberculosis, lower respiratory tract infections, HIV and climate-change-driven infectious diseases, among other topics.
More Information
Horizon Europe 2026-27: Cancer Mission
2026 calls close 15 Sep 2026; 2027 calls close 21 Sep 2027
Improving the lives of more than 3 million people by 2030 through prevention, cure and for those affected by cancer including their families, to live longer and better.
More Information
Horizon Europe 2026-2027: Health, Cluster 1
Various closing dates from Apr 2026 to Sep 2027
Topics available under Horizon Europe's Health programme for 2026/27, with funding of up to €90m per call.
More Information
Related Events and Recordings
Wed
10
Dec
2025
From molecules to manufacturing: The role of metrology in medicines development and manufacturing – a sustainability focus
13.00 - 14.15 | Online
Watch now
Tue
14
May
2024
Inside Out: Navigating Innovation in Intracellular Drug Delivery – Exploring Cutting-Edge Technologies
10.00 - 12.00 | Online
Watch now
Fri
24
Jan
2025
Shaping the future of medical products: Data-driven innovation and regulatory perspectives from the MHRA
11.00 - 12.00 | Online
Watch now
Related programmes
Medimap: End-to-end medicines supply chain map
Medimap is a new interactive reference tool for the UK medicines sector, mapping and categorising over 3,000 sites of organisations engaged in or supporting the end-to-end supply chain for medicines.
Health Funding Map
The map was developed by Innovate UK Business Connect and the BioIndustry Association (BIA) with the help of a wide range of funders. It helps in the navigation of the complicated world of health innovation funding.
Transforming Medicines Manufacturing
Innovate UK’s Transforming Medicines Manufacturing programme aims to drive the de-risking and adoption of highly innovative flexible, agile and scalable manufacturing technologies through a culture of collaboration that will drive the growth of this critically important manufacturing sector.